
...

By Adeola Adeosun
Weekend Night Editor
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer.
The jury awarded $18 million to Monica Kent and $22 million to Deborah Schultz and her husband. This verdict marks the latest development in ongoing litigation over claims that talc in Johnson's Baby Powder and Shower to Shower body powder was connected to ovarian cancer and mesothelioma, a cancer that strikes the lungs and other organs.
Erik Haas, Johnson & Johnson's worldwide vice president of litigation, said in a statement that the company had won “16 of the 17 ovarian cancer cases it previously tried” and expected to do so again upon appealing Friday's verdict.
Read More on News
He also called the jury's findings "irreconcilable with the decades of independent scientific evaluations confirming that talc is safe, does not contain asbestos, and does not cause cancer.''
Newsweek has reached out to Johnson & Johnson via email on Saturday for comment.
Why It Matters
This case adds to mounting legal challenges facing Johnson & Johnson over its talc-based products, with implications for thousands of similar claims nationwide.
The verdict comes months after a U.S. bankruptcy court judge denied the company's proposed $9 billion settlement plan in April, forcing Johnson & Johnson to litigate individual cases rather than resolve claims through bankruptcy proceedings.
What To Know
Johnson & Johnson has faced persistent legal battles over allegations that its talc products caused cancer. In October, another California jury ordered the company to pay $966 million to the family of a woman who died of mesothelioma, claiming the baby powder she used was contaminated with asbestos. The company discontinued talcum-based powder globally in 2023 after years of declining sales and mounting legal pressure.
This marks the third bankruptcy case for a Johnson & Johnson subsidiary related to the baby powder issue. Red River Talc LLC, a Johnson & Johnson subsidiary, sought confirmation of a proposed prepackaged Chapter 11 bankruptcy plan that would have paid $9 billion to settle ovarian cancer and other gynecological cancer litigation claims. Judge Christopher Lopez of the U.S. Bankruptcy Court for the Southern District of Texas ruled in April that Johnson & Johnson used a faulty voter solicitation process when dealing with personal injury claimants.
Following the bankruptcy denial, Johnson & Johnson announced it would not pursue an appeal and instead return to the civil law system to litigate individual claims. The company reversed approximately $7 billion of a previous reserve and stated it has settled 95 percent of filed mesothelioma lawsuits, concluded all state consumer protection claims, and resolved all talc-supplier disputes. Johnson & Johnson replaced talc with cornstarch in its baby powder sold in most of North America in 2020.
What People Are Saying
Daniel Robinson, attorney for Kent and Schultz, Robinson Calcagnie law firm told the Associated Press: "The only thing they did was be loyal to Johnson & Johnson as a customer for only 50 years. That loyalty was a one-way street."
Erik Haas, Johnson & Johnson's worldwide vice president of litigation said the company had won: "16 of the 17 ovarian cancer cases it previously tried." Haas called the jury's findings "irreconcilable with the decades of independent scientific evaluations confirming that talc is safe, does not contain asbestos, and does not cause cancer."

...
What Happens Next
Johnson & Johnson plans to appeal the verdict.
Reporting from the Associated Press contributed to this article.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines